Single-cell sequencing vs. Schistosoma mansoni
Cell atlas of tropical disease parasite could highlight new targets for treatment
Infectious Disease & Vaccines
Blending datasets for better research
AI collaboration seeks to improve access to COVID-19 datasets across institutions
Developing antibodies against SARS-CoV-2
DIOS-202 and DIOS-203 have been engineered for high potency and potential for avoiding escape mutants
Global effort on a neglected tropical disease
Health partners team up to speed up development of new schistosomiasis test
A COVID-19 home testing team-up
BD has partnered with Scanwell Health for an at-home rapid test for COVID-19
Developing a COVID-19 skin test
Intradermal test is designed to measure SARS-CoV-2-specific delayed type hypersensitivity
OliX launches mCureX for mRNA vaccines
OliX Pharmaceuticals spins out new subsidiary for developing mRNA vaccines and therapeutics
Johnson & Johnson submits EUA for COVID-19 vaccine
Johnson & Johnson applies to FDA for an EUA for its single-shot Janssen COVID-19 vaccine candidate
NVX-CoV2373 achieves notable efficacy in Phase 3 trial
Novavax’s NVX-CoV2373 first to demonstrate clinical efficacy against the UK and South Africa variants of COVID-19
Off to a good start
Initial data from Regeneron's Phase 3 trial of REGEN-COV show that the passive vaccine reduces COVID-19 infections and viral shedding
